So-Young International Inc., the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, announced that Mr. Min Yu, Mr. Xuejian Li, Mr. Charles Zhaoxuan Yang and Mr. Harry Jiannan Wang have tendered their resignations as directors of the Company for personal reasons, effective as of […]
So-Young Announces Board Change – October 12, 2023 Read More »
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will release third-quarter 2023 financial results before the market opens on Thursday, October 26, 2023, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
Genentech, a member of the Roche Group, announced new clinical and real-world data for Ocrevus® demonstrating its role in continuing to transform care for people living with relapsing or primary progressive multiple sclerosis presented at the 9th Joint ECTRIMS-ACTRIMS Meeting.
Neoss Group, a leading innovator in dental implant solutions, is proud to announce that it has received EU Medical Device Regulation certification by its Notified Body, the BSI Group, the Netherlands B.V. for its implants and abutments.
AbbVie announced that its Phase 2b study evaluating upadacitinib in adults with non-segmental vitiligo met the primary endpoint of percent change from baseline in the Facial Vitiligo Area Scoring Index at week 24 with the 11 mg and 22 mg doses versus placebo.
Mestag Therapeutics announced the appointment of expert advisors Dr. Cassandra Choe-Juliak MD, formerly Chief Medical Officer at Flame Biosciences; Dr. Greg Elson, an expert in end-to-end development of novel antibody-based products with more than 30 years of industry experience; and Samantha Vieira MBA PMP, formerly Chief Operating Officer at Anjarium Biosciences.
Victrex plc, a pioneer in the development of PEEK biomaterial solutions, have launched a new product grade developed exclusively for Drug Delivery and Pharmaceutical Contact applications.
AlzeCure Pharma AB announced that the company’s presentation at the pain conference held by the Swedish Pain Society is now available in its entirety on the company’s website.
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, announces that Dr. Jeffrey Lawson, currently the Company’s Chief Scientific Officer, will assume the role of CEO, succeeding Dr. Jan Öhrström who will continue as Chairman.
Photocure ASA, the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has unveiled the results of its Hexvix® Phase III clinical trial in China.
